M08.261
Juvenile rheumatoid arthritis with systemic onset, right knee
Clinical Classification Guidelines
Medical Intelligence & Overview
Juvenile rheumatoid arthritis (JRA), also known as juvenile idiopathic arthritis (JIA), is a chronic condition that affects children and adolescents, causing joint inflammation and stiffness. The specific form, juvenile rheumatoid arthritis with systemic onset (ICD-10 code M08.261), involves not only joint issues but also systemic symptoms affecting the entire body. When it impacts the right knee, it can lead to swelling, pain, and difficulties in mobility, influencing a child's daily activities and development. Early awareness and appropriate management are essential to control symptoms and prevent long-term joint damage.
Causes & Symptoms
Clinical Causes: Genetic predisposition, where certain gene variations increase the risk. Immune system dysfunction, leading the body's immune response to mistakenly attack healthy tissues, including joints. Environmental factors, such as infections, which might trigger or exacerbate the condition in genetically predisposed children.
Key Symptoms: Persistent swelling and pain in the right knee. Stiffness, especially after periods of inactivity or in the mornings. Fever that may be intermittent or persistent. Rash, often flat and pink, appearing across the body. General fatigue and tiredness. Enlargement of lymph nodes. Weight loss or decline in appetite.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of juvenile rheumatoid arthritis with systemic onset involves a combination of medical history review, physical examination, and laboratory tests. Key components include: - Medical history focusing on joint symptoms and systemic features. - Physical exam noting swelling, warmth, and range of motion of the right knee and other joints. - Laboratory tests such as blood counts, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and autoantibodies to assess inflammation. - Imaging studies like X-rays or MRI scans to evaluate joint damage or inflammation. - Ruling out other potential causes of joint symptoms, such as infections or other autoimmune conditions.
Treatment Protocols: Managing juvenile rheumatoid arthritis with systemic onset involves a multifaceted approach aimed at controlling inflammation, relieving pain, and preventing joint damage. Typical treatment options include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. - Corticosteroids, used cautiously to manage severe symptoms or flares. - Disease-modifying antirheumatic drugs (DMARDs), like methotrexate, to slow disease progression. - Biologic agents targeting specific components of the immune system, such as tumor necrosis factor (TNF) inhibitors. - Physical therapy to maintain joint flexibility and muscle strength. - Regular monitoring by a pediatric rheumatologist to assess disease activity and modify treatment plans. - Supportive care, including joint protection strategies and education for patients and families to manage daily activities effectively.
Clinical Advice & FAQs
Billing Guidance
Is M08.261 a billable ICD-10 code?
Yes, M08.261 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.261?
Clinical documentation must specify the nature of Juvenile rheumatoid arthritis with systemic onset, right knee and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
